Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials

Trials

Volumn 21, Issue 1, 2020, Pages

  Sterne, Jonathan A C ^a,b   Diaz, Janet ^c   Villar, Jesús ^d,e   Murthy, Srinivas ^f   Slutsky, Arthur S ^g   Perner, Anders ^h   Jüni, Peter ^g   Angus, Derek C ⁱ   Annane, Djillali ^j   Azevedo, Luciano Cesar Pontes ^k   Du, Bin ^l   Dequin, Pierre Francois ^m,n   Gordon, Anthony C ^o   Green, Cameron ^p   Higgins, Julian P T ^a,b,q   Horby, Peter ^r   Landray, Martin J ^s,t,u   Lapadula, Giuseppe ^v   Le Gouge, Amelie ^w   Leclerc, Marie ^m   Savović, Jelena ^a,q   Tomazini, Bruno ^k   Venkatesh, Balasubramanian ^x   Webb, Steve ^p   Marshall, John C ^g   more..

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h Rigshospitalet   (Denmark)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^j UNIVERSITÉ PARIS SACLAY   (France)

^k HOSPITAL SÍRIO LIBANÊS   (Brazil)

^l PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^m UNIVERSITY HOSPITAL OF TOURS   (France)

ⁿ UNIVERSITÉ DE TOURS   (France)

^o IMPERIAL COLLEGE LONDON   (United Kingdom)

^p MONASH UNIVERSITY   (Australia)

^q UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^r UNIVERSITY OF OXFORD   (United Kingdom)

^s UNIVERSITY OF OXFORD   (United Kingdom)

^t UNIVERSITY OF OXFORD   (United Kingdom)

^u OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^v SAN GERARDO HOSPITAL   (Italy)

^w CHU BRETONNEAU   (France)

^x UNIVERSITY OF NEW SOUTH WALES   (Australia)

more..

Author keywords

Corticosteroid; COVID 19; Dexamethasone; Hydrocortisone; Meta analysis; Methylprednisolone; Mortality; Randomised controlled trial; Systematic Review

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; METHYLPREDNISOLONE; PLACEBO; CORTICOSTEROID; GLUCOCORTICOID;

ALL CAUSE MORTALITY; ARTICLE; CORONAVIRUS DISEASE 2019; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG EFFECT; DRUG MEGADOSE; GRADE APPROACH; HOSPITAL PATIENT; HUMAN; LOW DRUG DOSE; META ANALYSIS; MORTALITY RATE; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT PARTICIPATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT DURATION; BETACORONAVIRUS; CORONAVIRUS INFECTION; CRITICAL ILLNESS; PANDEMIC; VIRUS PNEUMONIA;

ADRENAL CORTEX HORMONES; BETACORONAVIRUS; CORONAVIRUS INFECTIONS; CRITICAL ILLNESS; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; METHYLPREDNISOLONE; PANDEMICS; PNEUMONIA, VIRAL; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85089987483     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-020-04641-3     Document Type: Article

References (0)